News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
News Daily News Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI Michael O'Riordan February 20, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Daily News Even After Recent ACS, Diabetic Patients With Multivessel Disease Fare Better With CABG L.A. McKeown December 11, 2017
News Daily News Secondary Prevention Lagging Behind in Women With Established Coronary Disease Todd Neale September 22, 2017
Presentation Global Geographic Variation in Patient Characteristics in PCI Clinical Trials September 15, 2017
News Daily News Patients in PCI Trials Vary Around the World, With Women Still Underrepresented Michael O'Riordan September 15, 2017
Presentation ESC 2017 PCI vs CABG in Patients with Type 1 Diabetes and Multivessel Disease Presenter: Martin J. Holzmann August 28, 2017
News Conference News ESC 2017 CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease Todd Neale August 26, 2017
News Daily News CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition Michael O'Riordan August 04, 2017
News Conference News EuroPCR 2017 BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI Michael O'Riordan May 18, 2017
News Daily News Women Without Diabetes Fare as Poorly as Diabetic Men Post-PCI L.A. McKeown January 30, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Daily News Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label? Yael L. Maxwell December 23, 2016
News Daily News Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients L.A. McKeown August 11, 2016